Abstract

The global prevalence of viral hepatitis is very high and seems to be rising over the years. The infection can profoundly affect pregnant women causing significant maternal and perinatal morbidity and mortality with some strains much worse than others.Hepatitis A (HAV) and E (HEV) which are transmitted mainly through the faecal-oral route present as acute hepatitis during pregnancy and are responsible for most local epidemic outbreaks. HAV infection remains self-limiting during pregnancy, while HEV has a higher prevalence and causes significant morbidity. It is also associated with a very high maternal mortality rate (20 %) and requires special attention in endemic areas. HEV vaccines do exist, but the WHO has yet to approve them for general use. Hepatitis B is the most prevalent form and is part of the ante-natal screening program. The presence of HBeAg is associated with high viral loads and infectivity. Antiviral therapy, preferably tenofovir (TDF), is recommended for mothers with viral load ≥ 200,000 IU/mL2), with the neonates receiving both active and passive immunisations. Hepatitis C and D are usually found as chronic infections in the pregnant and non-pregnant populations. Screening for hepatitis C during pregnancy and its subsequent management is still unsettled, but the introduction of direct-acting antiviral (DAA) drugs will change the picture if their safety is established in pregnancy. HDV is an incomplete virus linked to HBV and cannot establish an infection on its own. Controlling HBV is paramount to controlling HDV. HEV is quite prevalent and looked upon as hepatotropic. It seems to be quite prevalent in some blood donor populations and has a high co-infection rate with HCV. It has a high Mother-to-Child-Transmission (MTCT) but causes little or no illness in infected infants, and antenatal screening is not justified.This review summarises the prevalence, clinical picture, maternal, perinatal effects, and the management and prevention of hepatitis A, B, C, D, E and G viral infections during pregnancy.

Highlights

  • Viral hepatitis is a widespread infection affecting both the pregnant and the non-pregnant population

  • Viral hepatitis is caused by a diverse collection of viruses with differing structural biology, transmission, endemic patterns, and chronicity that share a common propensity to infect and replicate in human hepatocytes

  • These are referred to as hepatotropic viruses, and cause most hepatitis in the pregnant and non-pregnant populations. Viruses included in this group are Hepatitis viruses A, B, C, and E (HAV, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Hepatitis E virus (HEV)) [4,5]

Read more

Summary

Introduction

Viral hepatitis is a widespread infection affecting both the pregnant and the non-pregnant population. Infection during pregnancy may be associated with a higher risk of maternal complications, and early delivery may be indicated in some cases with severe liver dysfunction in the third trimester [25]. Occurs primarily at birth with the newborns at high risk of developing chronic HBV infection [41].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call